U.S. Specialty Stores Stock News

Vir Biotechnology announced that its global collaboration and licensing agreement with Astellas has closed, bringing in a US$240,000,000 upfront payment, a US$75,000,000 equity investment at US$10.36 per share, and near-term and potential milestone payments tied to the development and commercialization of VIR-5500 for metastatic prostate cancer. At the same time, Vir has begun enrolling an expansion cohort in its Phase 1 trial of VIR-5500 following early safety and anti-tumor signals,...

JinkoSolar Holding (JKS) is in focus after reporting a full year 2025 net loss of CN¥4,445.09 million on sales of CN¥65,497.65 million, along with softer quarterly results and cautious 2026 shipment guidance. See our latest analysis for JinkoSolar Holding. The 1 year total shareholder return of 39.57% contrasts with a year to date share price return of negative 23.12%. Recent 7 day and 90 day share price returns of negative 9.75% and negative 16.84% suggest momentum has faded as investors...

Beyond Meat (BYND) has drawn fresh investor attention after announcing a distribution agreement with Big Geyser for its Beyond Immerse functional beverages, along with a nationwide rollout of new plant based breakfast sausages. See our latest analysis for Beyond Meat. The recent Big Geyser partnership and breakfast sausage rollout come after a sharp rebound in the 7 day share price return of 75.76% and 30 day share price return of 66.76%, although the 1 year total shareholder return of 56.55%...

At its April 13, 2026 annual meeting, Otter Tail Corporation approved amended and restated bylaws adding an exclusive forum provision and announced key leadership changes, including appointing Tim Rogelstad as President and Tyler Nelson as Chief Financial Officer. By concentrating litigation in a designated court and elevating long-tenured utility leaders into top corporate roles, Otter Tail is tightening legal control while reinforcing continuity in its electric and manufacturing...

Why Jim Cramer’s Commentary Put Shake Shack (SHAK) Back on Investor Radar Recent bullish commentary from Jim Cramer on Shake Shack (SHAK), focused on potential strength in upcoming same store sales, has drawn fresh attention to the burger chain as investors reassess its fundamentals. See our latest analysis for Shake Shack. The recent buzz around Cramer’s comments comes as Shake Shack’s share price sits at $104.69, with a 1-month share price return of 19.47% and year-to-date share price...

In April 2026, T-Mobile announced that Serve Robotics’ new AI-powered conversational robot “Maggie” was unveiled at NVIDIA GTC, showcasing real-time, 5G-enabled human-robot interaction for sidewalk delivery in urban environments. The launch of Maggie highlights how combining edge computing with sidewalk delivery robots could accelerate the move toward more human-centric automation in everyday city logistics. Next, we’ll examine how Maggie’s 5G edge capabilities might influence Serve...

Investors may be considering whether Universal Health Services offers good value at its current share price, or whether the recent share price move has already reflected much of the opportunity. The stock last closed at US$179.72, with a 1.9% decline over 7 days, a 3.3% decline over 30 days, an 18.3% decline year to date, and a 14.9% gain over the past year. Recent coverage has focused on Universal Health Services as a major player in US healthcare services, with ongoing attention on how...

Ocular Therapeutix (NasdaqGM:OCUL) released new 52-week post hoc Phase 3 data for AXPAXLI in wet age-related macular degeneration. The SOL-1 trial data indicated better durability, strong sustained disease control, and safety outcomes compared to aflibercept. The company presented the findings at a major ophthalmology conference and plans to seek FDA approval with a single pivotal Phase 3 trial. Ocular Therapeutix focuses on therapies for eye diseases, with AXPAXLI (OTX TKI) aimed at...

Warrior Met Coal, Inc. recently affirmed a regular quarterly cash dividend of US$0.08 per share and previously filed a US$326.05 million shelf registration covering 3,775,000 common shares for an ESOP-related offering. Together, the ongoing dividend payments and sizeable employee stock ownership plan capacity highlight management’s focus on both shareholder cash returns and broader employee equity participation. Next, we’ll explore how the new ESOP-related shelf registration shapes Warrior...

If you are wondering whether Whirlpool's current share price reflects its true worth, this breakdown will help you see how the market is pricing the business today. The stock last closed at US$57.25, with a recent 2.2% gain over 7 days and 9.5% over 30 days, set against a return of 23.2% decline year to date and 21.4% decline over the past year. Recent attention around Whirlpool has focused on its position in the household appliances market and how investors are weighing that against wider...

The United States market has experienced a notable upswing, climbing 3.6% in the last week and rising 39% over the past year, with earnings projected to grow by 16% annually. In this environment, identifying stocks that may be trading below their estimated intrinsic value can present compelling opportunities for investors seeking to capitalize on potential market inefficiencies.

MaxLinear’s recent share performance in context With no single event driving headlines, MaxLinear (MXL) has drawn attention after a sharp share price move, including a 20.8% gain over the past day and 91.6% over the past month. See our latest analysis for MaxLinear. The latest move builds on strong momentum, with a 71.4% year to date share price return and a 220.2% 1 year total shareholder return. This suggests a meaningful shift in how the market is pricing MaxLinear’s prospects and...

Agree Realty (NYSE:ADC) has approved increases to both its common and preferred dividends following board authorization. The updated payouts represent a change in the company’s dividend policy that is material for existing and prospective shareholders. These actions follow a period in which the stock has returned 10.3% year to date and 38.7% over 5 years, with the latest close at $79.56. For investors watching dividend income, Agree Realty’s new board-approved increases to both common and...

The United States market has recently experienced a notable upswing, climbing 3.6% in the last week and showing a robust 39% increase over the past year, with earnings projected to grow by 16% annually in the coming years. In this favorable environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong confidence from those who know the business best and have vested interests in its success.

The market has shown impressive growth, climbing 3.6% over the last week and 39% in the past year, with earnings forecasted to grow by 16% annually. While the term 'penny stocks' might seem outdated, these stocks continue to offer a unique blend of affordability and potential growth when backed by solid financials. In this article, we explore several penny stocks that stand out for their financial strength and potential as under-the-radar opportunities for investors.

The United States market has experienced a notable upswing, rising 3.6% in the past week and 39% over the last year, with earnings projected to grow by 16% annually in the coming years. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can uncover promising opportunities often overlooked by mainstream investors.

American Well Corporation ( NYSE:AMWL ) shareholders may have reason to be concerned, as several insiders sold their...

Last week, First Watch Restaurant Group, Inc.'s (NASDAQ:FWRG) stock jumped 16%, but insiders who sold US$4.6m worth of...

One thing we could say about the analysts on Monte Rosa Therapeutics, Inc. ( NASDAQ:GLUE ) - they aren't optimistic...

The Morning Bull - US Market Morning Update Tuesday, Apr, 21 2026 US stock futures point higher this morning, with E-mini S&P 500 contracts up about 0.25% and Nasdaq-100 minis up around 0.38%, as investors weigh strong global demand against rising government borrowing costs and inflation worries. Taiwan’s export orders hit a record US$91.1b in March, up 65.9% from a year earlier, which signals powerful demand for electronics and chips that feed into many US tech and manufacturing names. At...

TopBuild’s recent share performance in focus TopBuild (BLD) has drawn attention after a sharp move in its share price, with the stock showing strong recent returns over the past week, month, and past three months. See our latest analysis for TopBuild. Zooming out, the recent surge in TopBuild’s share price, including a 19.38% 1 day share price return and 46.03% 30 day share price return, sits alongside a 77.11% 1 year total shareholder return. This points to strong momentum rather than a...

One thing we could say about the analysts on Viridian Therapeutics, Inc. ( NASDAQ:VRDN ) - they aren't optimistic...

Some investors may be wondering if TD SYNNEX at around US$217.88 still offers value after a strong run, or if most of the easy upside is already behind it. The stock shows returns of 5.5% over 7 days, 42.6% over 30 days, 42.0% year to date, 113.9% over 1 year, 155.8% over 3 years, and 84.8% over 5 years. This puts recent price action firmly on many investors' radar. Recent coverage has focused on TD SYNNEX's position in technology distribution and solutions, as well as how it is responding...

Pharvaris recently presented data at the April 17–19, 2026 Consortium of Independent Immunology Clinics conference showing that combining deucrictibant extended-release tablets for prophylaxis with immediate-release capsules for breakthrough hereditary angioedema attacks is supported by evidence of adequate safety margins. An additional post-hoc analysis comparing icatibant-treated breakthrough attacks in both placebo and deucrictibant arms offers early insight into how pairing a...